418 related articles for article (PubMed ID: 29250791)
61. Determination of optimal timing of serial in-utero transfusions in red-cell alloimmunization.
Friszer S; Maisonneuve E; Macé G; Castaigne V; Cortey A; Mailloux A; Pernot F; Carbonne B
Ultrasound Obstet Gynecol; 2015 Nov; 46(5):600-5. PubMed ID: 25523966
[TBL] [Abstract][Full Text] [Related]
62. Direct fetal intravenous immunoglobulin infusion as an adjunct to intrauterine fetal blood transfusion in rhesus-allommunized pregnancies: a pilot study.
Deka D; Sharma KA; Dadhwal V; Singh A; Kumar G; Vanamail P
Fetal Diagn Ther; 2013; 34(3):146-51. PubMed ID: 23941890
[TBL] [Abstract][Full Text] [Related]
63. Intrauterine Fetal Blood Transfusion: Descriptive study of the first four years' experience in Oman.
Al-Riyami AZ; Al-Salmani M; Al-Hashami SN; Al-Mahrooqi S; Al-Marhoobi A; Al-Hinai S; Al-Hosni S; Panchatcharam SM; Al-Arimi ZA
Sultan Qaboos Univ Med J; 2018 Feb; 18(1):e34-e42. PubMed ID: 29666679
[TBL] [Abstract][Full Text] [Related]
64. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
[TBL] [Abstract][Full Text] [Related]
65. Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures.
Zwiers C; Lindenburg ITM; Klumper FJ; de Haas M; Oepkes D; Van Kamp IL
Ultrasound Obstet Gynecol; 2017 Aug; 50(2):180-186. PubMed ID: 27706858
[TBL] [Abstract][Full Text] [Related]
66. Management and prevention of red cell alloimmunization in pregnancy: a systematic review.
Moise KJ; Argoti PS
Obstet Gynecol; 2012 Nov; 120(5):1132-9. PubMed ID: 23090532
[TBL] [Abstract][Full Text] [Related]
67. A case of severe hemolytic disease of newborn due to alloimmunization in primigravida.
Pandey P; Kumari S; Mandal S; Sawhney A; Jain R
Transfus Clin Biol; 2023 Feb; 30(1):5-7. PubMed ID: 35944885
[TBL] [Abstract][Full Text] [Related]
68. Successful Management of the Fetal Severe Anemia Associated with Jra Alloimmunization by Intrauterine Transfusion of Jr(a+) Red Blood Cells.
Toshimitsu M; Nagaoka S; Kobori S; Takahashi Y; Murotsuki J
Case Rep Obstet Gynecol; 2019; 2019():5174989. PubMed ID: 30918730
[TBL] [Abstract][Full Text] [Related]
69. [Fetal plasma erythropoietin concentration during intrauterine transfusion therapy in isoimmunohemolytic anemia due to rhesus incompatibility].
Hebgen A; Schiffer-N'Gampolo D; Bald R; Hansmann M; Bode U
Ultraschall Med; 1997 Aug; 18(4):162-4. PubMed ID: 9381123
[TBL] [Abstract][Full Text] [Related]
70. Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis.
Gudlaugsson B; Hjartardottir H; Svansdottir G; Gudmundsdottir G; Kjartansson S; Jonsson T; Gudmundsson S; Halldorsdottir AM
Transfusion; 2020 Jan; 60(1):175-183. PubMed ID: 31850521
[TBL] [Abstract][Full Text] [Related]
71. Benefits and risks of fetal red-cell transfusion after 32 weeks gestation.
Klumper FJ; van Kamp IL; Vandenbussche FP; Meerman RH; Oepkes D; Scherjon SA; Eilers PH; Kanhai HH
Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):91-6. PubMed ID: 10986440
[TBL] [Abstract][Full Text] [Related]
72. Management of rhesus alloimmunization in pregnancy.
Moise KJ
Obstet Gynecol; 2008 Jul; 112(1):164-76. PubMed ID: 18591322
[TBL] [Abstract][Full Text] [Related]
73. Noninvasive approach for the management of hemolytic disease of the fetus.
Illanes S; Soothill P
Expert Rev Hematol; 2009 Oct; 2(5):577-82. PubMed ID: 21083022
[TBL] [Abstract][Full Text] [Related]
74. Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus.
Li S; He Z; Mo C; Ji Y; Luo Y; Fang Q; Gao Y
Transfusion; 2021 Jun; 61(6):1908-1915. PubMed ID: 33938570
[TBL] [Abstract][Full Text] [Related]
75. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
[TBL] [Abstract][Full Text] [Related]
76. Intravenous immune globulin in the management of severe Rh D hemolytic disease.
Porter TF; Silver RM; Jackson GM; Branch DW; Scott JR
Obstet Gynecol Surv; 1997 Mar; 52(3):193-7. PubMed ID: 9061721
[TBL] [Abstract][Full Text] [Related]
77. A Jordanian family with three sisters apparently homozygous for M
Al-Jada NA
Transfusion; 2017 Feb; 57(2):376-378. PubMed ID: 27807866
[TBL] [Abstract][Full Text] [Related]
78. [Follow-up of pregnancies with red-cell allo-immunisation: State-of-the art].
Carbonne B; Castaigne V; Cynober E; Levy R; Cortey A; Mailloux A; Larsen M; Brossard Y
Gynecol Obstet Fertil; 2010 Mar; 38(3):205-13. PubMed ID: 20207183
[TBL] [Abstract][Full Text] [Related]
79. Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.
Rath ME; Smits-Wintjens VE; Lindenburg IT; Folman CC; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
Transfusion; 2013 Jul; 53(7):1580-5. PubMed ID: 23113703
[TBL] [Abstract][Full Text] [Related]
80. Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model.
Stowell SR; Henry KL; Smith NH; Hudson KE; Halverson GR; Park JC; Bennett AM; Girard-Pierce KR; Arthur CM; Bunting ST; Zimring JC; Hendrickson JE
Blood; 2013 Aug; 122(8):1494-504. PubMed ID: 23801629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
